Literature DB >> 893388

Purification of human fibroblast interferon by zinc chelate affinity chromatography.

V G Edy, A Billiau, P de Somer.   

Abstract

Zinc chelated by iminodiacetic acid linked to an insoluble matrix binds human fibroblast interferon quite selectively at neutral pH in 0.15 M NaCL. On reduction of the pH and increase of the ionic strength, the interferon is eluted. Using a pH gradient at constant high ionic strength, good purification of the interferon can be obtained, up to a final specific activity of 108.5 units/mg of protein. Approximately 60% of the applied activity can be recovered.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 893388

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Large-scale production and partial purification of mouse immune interferon.

Authors:  L C Osborne; J A Georgiades; H M Johnson
Journal:  Infect Immun       Date:  1979-01       Impact factor: 3.441

2.  Lack of detectable nuclease activity in highly purified preparations of murine fibroblast interferon.

Authors:  J N Wood
Journal:  Mol Biol Rep       Date:  1979-12-31       Impact factor: 2.316

3.  Metal chelate affinity chromatography of hamster interferon.

Authors:  E Bollin; E Sulkowski
Journal:  Arch Virol       Date:  1978       Impact factor: 2.574

4.  Affinity chromatography of primary human amnion interferon.

Authors:  P C Ferreira; M Paucker; R R Golgher; K Paucker
Journal:  Arch Virol       Date:  1981       Impact factor: 2.574

5.  Large-scale production and physicochemical characterization of human immune interferon.

Authors:  M P Langford; J A Georgiades; G J Stanton; F Dianzani; H M Johnson
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

6.  Human fibroblast interferon for clinical trials: pharmacokinetics and tolerability in experimental animals and humans.

Authors:  A Billiau; P De Somers; V G Edy; E De Clercq; H Heremans
Journal:  Antimicrob Agents Chemother       Date:  1979-07       Impact factor: 5.191

7.  Interferon-beta in patients with low-grade astrocytomas--a phase I study.

Authors:  U Bogdahn; B Fleischer; J Hilfenhaus; H J Röthig; P Krauseneck; H G Mertens; H Przuntek
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.